201 related articles for article (PubMed ID: 16868444)
1. Risk factors for osteonecrosis in HIV-infected patients: impact of treatment with combination antiretroviral therapy.
Mary-Krause M; Billaud E; Poizot-Martin I; Simon A; Dhiver C; Dupont C; Salmon D; Roudiere L; Costagliola D;
AIDS; 2006 Aug; 20(12):1627-35. PubMed ID: 16868444
[TBL] [Abstract][Full Text] [Related]
2. HIV-associated Isospora belli infection: incidence and risk factors in the French Hospital Database on HIV.
Guiguet M; Furco A; Tattevin P; Costagliola D; Molina JM;
HIV Med; 2007 Mar; 8(2):124-30. PubMed ID: 17352769
[TBL] [Abstract][Full Text] [Related]
3. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
[TBL] [Abstract][Full Text] [Related]
4. Fungal infection as a risk factor for HIV disease progression among patients with a CD4 count above 200/microl in the era of cART.
Podlekareva D; Mocroft A; Kirk O; Reiss P; Aldins P; Katlama C; Kovari H; Stellbrink HJ; D'Arminio Monforte A; Lundgren JD;
Scand J Infect Dis; 2008; 40(11-12):908-13. PubMed ID: 18609197
[TBL] [Abstract][Full Text] [Related]
5. Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score.
Mocroft A; Ledergerber B; Zilmer K; Kirk O; Hirschel B; Viard JP; Reiss P; Francioli P; Lazzarin A; Machala L; Phillips AN; Lundgren JD;
AIDS; 2007 Sep; 21(14):1867-75. PubMed ID: 17721094
[TBL] [Abstract][Full Text] [Related]
6. Symptomatic bone disorders in HIV-infected patients: incidence in the Aquitaine cohort (1999-2002).
Martin K; Lawson-Ayayi S; Miremont-Salamé G; Blaizeau MJ; Balestre E; Lacoste D; Ragnaud JM; Malvy D; Dupon M; Mercié P; Schaeverbeke T; Haramburu F; Dabis F;
HIV Med; 2004 Nov; 5(6):421-6. PubMed ID: 15544694
[TBL] [Abstract][Full Text] [Related]
7. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study.
Sogaard OS; Lohse N; Gerstoft J; Kronborg G; Ostergaard L; Pedersen C; Pedersen G; Sørensen HT; Obel N
Clin Infect Dis; 2008 Nov; 47(10):1345-53. PubMed ID: 18834317
[TBL] [Abstract][Full Text] [Related]
8. CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis.
Seminari E; De Silvestri A; Boschi A; Tinelli C
AIDS Rev; 2008; 10(4):236-44. PubMed ID: 19092979
[TBL] [Abstract][Full Text] [Related]
9. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
Khanna N; Elzi L; Mueller NJ; Garzoni C; Cavassini M; Fux CA; Vernazza P; Bernasconi E; Battegay M; Hirsch HH;
Clin Infect Dis; 2009 May; 48(10):1459-66. PubMed ID: 19348592
[TBL] [Abstract][Full Text] [Related]
10. The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study.
Law MG; Friis-Møller N; El-Sadr WM; Weber R; Reiss P; D'Arminio Monforte A; Thiébaut R; Morfeldt L; De Wit S; Pradier C; Calvo G; Kirk O; Sabin CA; Phillips AN; Lundgren JD;
HIV Med; 2006 May; 7(4):218-30. PubMed ID: 16630034
[TBL] [Abstract][Full Text] [Related]
11. Combination antiretroviral therapy and the risk of myocardial infarction.
Friis-Møller N; Sabin CA; Weber R; d'Arminio Monforte A; El-Sadr WM; Reiss P; Thiébaut R; Morfeldt L; De Wit S; Pradier C; Calvo G; Law MG; Kirk O; Phillips AN; Lundgren JD;
N Engl J Med; 2003 Nov; 349(21):1993-2003. PubMed ID: 14627784
[TBL] [Abstract][Full Text] [Related]
12. Incidence and risk factors of nevirapine-associated severe hepatitis among HIV-infected patients with CD4 cell counts less than 250 cells/microL.
Manosuthi W; Sungkanuparph S; Tansuphaswadikul S; Chottanapund S; Mankatitham W; Chimsuntorn S; Sittibusaya C; Moolasart V; Chaovavanich A
J Med Assoc Thai; 2008 Feb; 91(2):159-65. PubMed ID: 18389979
[TBL] [Abstract][Full Text] [Related]
13. Differential impact of combination antiretroviral therapy in preventing Kaposi's sarcoma with and without visceral involvement.
Grabar S; Abraham B; Mahamat A; Del Giudice P; Rosenthal E; Costagliola D
J Clin Oncol; 2006 Jul; 24(21):3408-14. PubMed ID: 16849755
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for incident diabetes mellitus among HIV-infected patients receiving combination antiretroviral therapy in Taiwan: a case-control study.
Lo YC; Chen MY; Sheng WH; Hsieh SM; Sun HY; Liu WC; Wu PY; Wu CH; Hung CC; Chang SC
HIV Med; 2009 May; 10(5):302-9. PubMed ID: 19220492
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
[TBL] [Abstract][Full Text] [Related]
16. Osteonecrosis in patients infected with human immunodeficiency virus: a case-control study.
Glesby MJ; Hoover DR; Vaamonde CM
J Infect Dis; 2001 Aug; 184(4):519-23. PubMed ID: 11471113
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral treatment and age-related comorbidities in a cohort of older HIV-infected patients.
Orlando G; Meraviglia P; Cordier L; Meroni L; Landonio S; Giorgi R; Fasolo M; Faggion I; Riva A; Zambelli A; Beretta R; Gubertini G; Dedivitiis G; Jacchetti G; Cargnel A
HIV Med; 2006 Nov; 7(8):549-57. PubMed ID: 17105515
[TBL] [Abstract][Full Text] [Related]
18. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
[TBL] [Abstract][Full Text] [Related]
19. Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002.
Lampe FC; Gatell JM; Staszewski S; Johnson MA; Pradier C; Gill MJ; de Lazzari E; Dauer B; Youle M; Fontas E; Krentz HB; Phillips AN
Arch Intern Med; 2006 Mar; 166(5):521-8. PubMed ID: 16534038
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.
Ruiz L; Paredes R; Gómez G; Romeu J; Domingo P; Pérez-Alvarez N; Tambussi G; Llibre JM; Martínez-Picado J; Vidal F; Fumaz CR; Clotet B;
AIDS; 2007 Jan; 21(2):169-78. PubMed ID: 17197807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
